Acute Heart Failure Registry: Risk Assessment Model in Decompensated Heart Failure
نویسندگان
چکیده
منابع مشابه
Acute Heart Failure Registry: Risk Assessment Model in Decompensated Heart Failure
BACKGROUND Heart failure (HF) is a highly prevalent syndrome. Although the long-term prognostic factors have been identified in chronic HF, this information is scarcer with respect to patients with acute HF. despite available data in the literature on long-term prognostic factors in chronic HF, data on acute HF patients are more scarce. OBJECTIVES To develop a predictor of unfavorable prognos...
متن کاملAcute Decompensated Heart Failure
eart failure has emerged over the past several decades as a major global public health problem, with rising prevalence reported in both industrialized and developing nations alike.1–6 In addition to the enormous costs in human suffering and loss of productivity, heart failure has imposed an increasingly heavy financial burden on health-care systems throughout the world. Although highly effectiv...
متن کاملAcute Decompensated Heart Failure
cute decompensated heart failure is among the most ommon indications for hospitalization in the U.S. and esults in approximately one million hospitalizations annully (1). Although consensus guidelines provide evidenceased strategies for the treatment of chronic heart failure, he current therapy of acute heart failure is largely empirical. he first priority of management is relief of symptoms. A...
متن کاملAcute Decompensated Heart Failure Update
Acute decompensated heart failure (ADHF) continues to increase in prevalence and is associated with substantial mortality and morbidity including frequent hospitalizations. The American Heart Association is predicting that more than eight million Americans will have heart failure by 2030 and that the total direct costs associated with the disease will rise from $21 billion in 2012 to $70 billio...
متن کاملAssessment of Dyspnea in Acute Decompensated Heart Failure
Results Patients were median age 70 years, and 34% were female; no significant differences between nesiritide or placebo patients existed. Median baseline PEFR was 225 l/min (interquartile range [IQR]: 160 to 300 l/min) and increased to 230 l/min (2.2% increase; IQR: 170 to 315 l/min) by hour 1, 250 l/min (11.1% increase; IQR: 180 to 340 l/min) by hour 6, and 273 l/min (21.3% increase; IQR: 200...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arquivos Brasileiros de Cardiologia
سال: 2016
ISSN: 0066-782X
DOI: 10.5935/abc.20160178